TrialBMC cancer2016

Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.

Cheng-Che Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.